10-Q: inTEST Corp Reports Q1 2024 Results, Impacted by Semiconductor Market Slowdown
Quarterly Report
inTEST Corp's first quarter 2024 results show a decrease in revenue and gross margin compared to the same period last year, primarily due to a slowdown in the semiconductor market, despite growth in other sectors.
Summary
- inTEST Corp's revenue for the first quarter of 2024 was $29.8 million, a decrease from $31.9 million in the same period of 2023.
- The company's gross margin decreased to 44% in Q1 2024 from 47% in Q1 2023.
- Operating income for the quarter was $492,000, significantly lower than the $3.5 million reported in the first quarter of 2023.
- Net earnings for Q1 2024 were $662,000, a substantial decrease from $2.8 million in Q1 2023.
- The company completed the acquisition of Alfamation S.p.A. on March 12, 2024, for approximately EUR 20 million, including cash and stock.
- inTEST's backlog at the end of Q1 2024 was $55.5 million, which includes $22.8 million from Alfamation.
- The company's cash and cash equivalents decreased to $27.3 million at the end of Q1 2024 from $45.3 million at the end of 2023.
Sentiment
Score: 4
Explanation: The document presents a mixed picture. While the acquisition of Alfamation and backlog growth are positive, the significant declines in revenue, gross margin, and earnings, along with the identified material weakness, create a negative sentiment. The company is facing challenges in its core market, and the overall tone is cautious.
Positives
- The company successfully completed the acquisition of Alfamation, expanding its presence in the automotive, life sciences, and consumer electronics markets.
- Backlog increased to $55.5 million, suggesting potential for future revenue growth.
- The company is actively diversifying its markets to reduce dependence on the semiconductor industry.
- The company has extended the period during which they may request advances under the Term Note until May 2, 2026, and the Term Note and revolving credit facility maturity date is extended from September 19, 2027 to May 2, 2031.
Negatives
- Revenue decreased by 6.6% year-over-year, primarily due to reduced demand in the semiconductor market.
- Gross margin declined to 44% from 47% year-over-year, due to lower revenue and increased fixed operating costs.
- Operating income saw a significant decrease, falling from $3.5 million to $492,000 year-over-year.
- Net earnings decreased substantially from $2.8 million to $662,000 year-over-year.
- Cash and cash equivalents decreased to $27.3 million from $45.3 million at the end of the previous quarter.
- The company identified a material weakness in its internal control over financial reporting related to the procurement and sale of discontinued materials.
Risks
- The company is exposed to the cyclical nature of the semiconductor market, which can cause significant fluctuations in demand and revenue.
- The company relies on a relatively small number of customers for a significant portion of its sales, creating customer concentration risk.
- The company faces risks related to supply chain disruptions, including the ongoing war in Ukraine and the conflict in Israel.
- The company's ability to integrate acquired businesses, such as Alfamation, may impact future performance.
- The company identified a material weakness in its internal control over financial reporting, which could lead to future misstatements.
Future Outlook
The company anticipates that its cash and cash equivalents, combined with borrowing capacity and operating cash flows, will be sufficient to support short-term working capital and corporate requirements. They also plan to pursue acquisition opportunities and may fund these through a combination of cash, credit facility, or equity issuance.
Management Comments
- Management is focused on diversifying markets and reducing dependence on the semiconductor industry.
- Management is taking actions to mitigate supply chain risks, including qualifying new vendors and increasing inventory.
- Management believes that the company's products address test and process requirements in key target markets such as automotive, defense/aerospace, industrial, life sciences, and security.
Industry Context
The results reflect a broader trend of reduced demand in the semiconductor market, impacting companies that supply equipment and services to this sector. The company's diversification strategy is a response to the cyclical nature of the semiconductor industry, aiming to stabilize revenue streams by expanding into other markets.
Comparison to Industry Standards
- The decline in revenue and gross margin is consistent with the challenges faced by other companies in the semiconductor supply chain during periods of market downturn.
- The company's diversification strategy is a common approach among companies seeking to mitigate the impact of cyclical industries.
- The acquisition of Alfamation is a strategic move to expand into higher-growth markets, similar to actions taken by other companies in the sector.
- The company's backlog increase, including Alfamation, is a positive sign compared to some competitors who may be experiencing order declines.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| President of Process Technologies | NA | Newly appointed president | January 16, 2024 | New appointment |
Stakeholder Impact
- Shareholders will be concerned about the decreased revenue, gross margin, and earnings.
- Employees may be affected by the company's efforts to manage costs and integrate Alfamation.
- Customers may experience changes in product availability and pricing due to supply chain issues.
- Suppliers may be impacted by the company's efforts to diversify its supply chain.
Next Steps
- The company will continue to integrate Alfamation into its operations.
- The company will focus on diversifying its markets and reducing dependence on the semiconductor industry.
- The company will work to remediate the identified material weakness in internal control over financial reporting.
- The company will continue to monitor and address supply chain risks.
Key Dates
| Date | Description |
|---|---|
| March 29, 2010 | Original issue date of a letter of credit for Mt. Laurel, NJ facility. |
| October 27, 2010 | Original issue date of a letter of credit for Mansfield, MA facility. |
| October 15, 2021 | Date of the original Amended and Restated Loan and Security Agreement with M&T Bank. |
| October 28, 2021 | Date of the first draw under the Term Note to finance the acquisition of Videology and the date of the interest rate swap agreement. |
| December 29, 2021 | Date of the second draw under the Term Note to finance the acquisition of Acculogic. |
| September 20, 2022 | Date of the Third Amendment to Amended and Restated Loan and Security Agreement. |
| May 11, 2023 | Date the company entered into an At-the-Market Issuance Sales Agreement. |
| March 12, 2024 | Date of the acquisition of Alfamation S.p.A. |
| March 31, 2024 | End of the reporting period for the quarterly report. |
| May 1, 2024 | Number of shares of common stock outstanding as of this date: 12,489,642. |
| May 2, 2024 | Date of the Fourth Amendment to the Amended and Restated Loan and Security Agreement. |
| April 30, 2025 | Expiration date of a letter of credit for Mt. Laurel, NJ facility. |
| April 30, 2031 | Extended expiration date of a letter of credit for Mt. Laurel, NJ facility. |
| December 31, 2024 | Expiration date of a letter of credit for Mansfield, MA facility. |
Keywords
semiconductor, test equipment, Alfamation, acquisition, revenue, gross margin, backlog, financial results, internal control, supply chain
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.